- Home
- CDNA vs ACVA Comparison
CDNA vs ACVA Comparison
Compare CDNA & ACVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CDNA | ACVA |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2007 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CDNA | ACVA |
|---|---|---|
| Price | $21.60 | $5.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 12 |
| Target Price | ★ $28.00 | $11.32 |
| AVG Volume (30 Days) | 652.5K | ★ 3.7M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.75 |
| EPS | ★ 0.05 | N/A |
| Revenue | $48,324,000.00 | ★ $759,606,000.00 |
| Revenue This Year | $16.01 | $14.01 |
| Revenue Next Year | $11.31 | $12.62 |
| P/E Ratio | $429.80 | ★ N/A |
| Revenue Growth | 18.93 | ★ 19.22 |
| 52 Week Low | $10.96 | $4.07 |
| 52 Week High | $23.24 | $17.16 |
Technical Indicators
Market Signals| Indicator | CDNA | ACVA |
|---|---|---|
| Relative Strength Index (RSI) | 59.06 | 57.31 |
| Support Level | $15.80 | $4.86 |
| Resistance Level | $22.89 | $8.37 |
| Average True Range (ATR) | 1.00 | 0.39 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 76.54 | 52.40 |
Price Performance
Historical ComparisonAbout CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About ACVA ACV Auctions Inc.
ACV Auctions Inc operates a mobile platform for wholesale car auctions. It provides a digital marketplace for wholesale vehicle transactions and data services that offer transparent and accurate vehicle information for customers. Additionally, the company's marketplace platform is supported by remarketing centers in various locations throughout the United States.